YieldMax MRNA Option Income Strategy ETF
MRNY
10 hedge funds and large institutions have $25.9M invested in YieldMax MRNA Option Income Strategy ETF in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 6 closing their positions.
361% more call options, than puts
Call options by funds: $553K | Put options by funds: $120K
8.38% less ownership
Funds ownership: 29.53% → 21.15% (-8.4%)
17% less funds holding
Funds holding: 12 → 10 (-2)
30% less capital invested
Capital invested by funds: $37.2M → $25.9M (-$11.3M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM
Winebrenner Capital Management
Louisville,
Kentucky
|
+$168K |
| 2 |
KCM
Key Capital Management
Hendersonville, Tn 37075,
Tennessee
|
+$1.69K |
| 3 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
+$202 |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$51 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
-$8.01M |
| 2 |
Jane Street
New York
|
-$1.95M |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$1.01M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$597K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$27.4K |
MRNY Hedge Fund Activity: Q2 2026 in Review
10 of the 8,323 institutional investors tracked by Wall St. Rank reported a position in YieldMax MRNA Option Income Strategy ETF (MRNY) for Q2 2026, worth a combined $25.9M — down 30% from $37.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MRNY and 4 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 0 added.
The largest buyer was Winebrenner Capital Management, opening a new position worth an estimated $168K. The largest seller was Tidal Investments, cutting an estimated $8.01M.
- 10 institutional investors held YieldMax MRNA Option Income Strategy ETF (MRNY) as of Q2 2026, down from 12 in Q1 2026.
- Funds reported $25.9M of YieldMax MRNA Option Income Strategy ETF stock for Q2 2026, down 30% quarter-over-quarter.
- 4 funds opened new YieldMax MRNA Option Income Strategy ETF positions in Q2 2026 and 6 closed out, a net change of -2 holders.
- The largest YieldMax MRNA Option Income Strategy ETF buyer in Q2 2026 was Winebrenner Capital Management, an estimated $168K added.
- The largest YieldMax MRNA Option Income Strategy ETF seller in Q2 2026 was Tidal Investments, an estimated $8.01M sold.
Based on aggregated 13F filings for Q2 2026.